Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Pediatr Infect Dis J. 2017 Jan;36(1):36–43. doi: 10.1097/INF.0000000000001342

Figure 2. One-way sensitivity analyses of incremental cost-effectiveness, comparing Xpert to current clinical practice alone for TB diagnosis in children.

Figure 2

Bars denote the ICER of Xpert relative to the standard of care at the high or low value of each parameter shown. Xpert was highly cost-effective relative to the standard of care except in settings of low probability of death from untreated TB, low Xpert sensitivity, or high sensitivity of current clinical practice. Results are similar for the diagnostic scenario of Clinical Diagnosis plus MODS (data not shown).